Marisa Holubar
Impact in
-
- Antibiotic Use and Resistance
- Infectious Diseases top 2%
- Antimicrobial Resistance in Staphylococcus
- Clostridium difficile and Clostridium perfringens research
- SARS-CoV-2 and COVID-19 Research
- Viral gastroenteritis research and epidemiology
Papers in
-
- Antibiotic Use and Resistance 14
-
- Viral gastroenteritis research and epidemiology 15
- Antimicrobial Resistance in Staphylococcus 15
- Clostridium difficile and Clostridium perfringens research 9
- SARS-CoV-2 and COVID-19 Research 7
- Co-authors
- Stan DeresinskiLina MengEmily MuiMary Ellen PerryLeslie SaucedoMichael DavidRichard WatkinsElizabeth Robilotti
- Journals
- Open Forum Infectious Diseases (19 papers)Clinical Infectious Diseases (6 papers)Journal of Clinical Microbiology (5 papers)Infection Control and Hospital Epidemiology (4 papers)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (3 papers)
- Partner nations
- United StatesMexicoBrazil
In The Last Decade
Marisa Holubar
69 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 106
- Applied Microbiology and Biotechnology 136
- Infectious Diseases 569
- Clinical Biochemistry 173
- Molecular Medicine 113
- Critical Care and Intensive Care Medicine 71
Countries citing papers authored by Marisa Holubar
This map shows the geographic impact of Marisa Holubar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marisa Holubar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marisa Holubar more than expected).
Fields of papers citing papers by Marisa Holubar
This network shows the impact of papers produced by Marisa Holubar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marisa Holubar. The network helps show where Marisa Holubar may publish in the future.
Co-authors
The 25 scholars most cited alongside Marisa Holubar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 15 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 17 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 1 | |
| 12 | 2023 | 1 | |
| 13 | 2022 | 19 | |
| 14 | 2021 | 36 | |
| 15 | 2021 | 17 | |
| 16 | 2021 | 4 | |
| 17 | 2020 | 19 | |
| 18 | 2017 | 4 | |
| 19 | 2016 | 5 | |
| 20 | 2013 | 18 |
About Marisa Holubar
Marisa Holubar is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases, Clinical Biochemistry, Epidemiology and Pharmacology, having authored 74 papers that have together received 1.2k indexed citations. Recurring topics across this work include Viral gastroenteritis research and epidemiology (15 papers), Antimicrobial Resistance in Staphylococcus (15 papers), Antibiotic Use and Resistance (14 papers), Bacterial Identification and Susceptibility Testing (13 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers), Clostridium difficile and Clostridium perfringens research (9 papers), Viral Infections and Immunology Research (8 papers) and SARS-CoV-2 and COVID-19 Research (7 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (136 citations), Infectious Diseases (569 citations), Clinical Biochemistry (173 citations), Molecular Medicine (113 citations) and Critical Care and Intensive Care Medicine (71 citations). Marisa Holubar has collaborated with scholars based in United States, Mexico and Brazil. Frequent co-authors include Stan Deresinski, Lina Meng, Emily Mui, Mary Ellen Perry, Leslie Saucedo, Michael David, Richard Watkins, Elizabeth Robilotti, Yvonne Maldonado and Niaz Banaei. Their work appears in journals such as Open Forum Infectious Diseases, Clinical Infectious Diseases, Journal of Clinical Microbiology, Infection Control and Hospital Epidemiology and Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.